IMVT
Immunovant Inc.
Company Overview
| Mkt Cap | $3.83B | Price | $23.85 |
| Volume | 1.24M | Change | -3.36% |
| P/E Ratio | -9.3 | Open | $24.40 |
| Revenue | -- | Prev Close | $24.68 |
| Net Income | $-413.8M | 52W Range | $12.72 - $32.10 |
| Div Yield | N/A | Target | $38.33 |
| Overall | 62 | Value | 55 |
| Quality | 31 | Technical | 100 |
No chart data available
Stock Overview
Updated DailyImmunovant Inc. (IMVT) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $24.68 with a market capitalization of $3.83 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows IMVT with a volume of 2.72 million shares. The stock opened up 0.24% from yesterday's close of $24.82. Current analyst estimates project earnings of $-2.87 per share for this year, with next year targeting $-2.92.
IMVT demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for IMVT include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 55.3%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 3, 2025 at 04:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMVT | $23.85 | -3.4% | 1.24M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |